Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Biochip for the diagnosis of Familial Hypercholesterolemia

10.02.2004


Hypercholesterolemia patients now have a new method of diagnosis that enables them to know for sure if they are suffering from Familial Hypercholesteloremia (FH) or not. The new tool, known as Lipochip, is the first biochip for the diagnosis of Familial Hypercholesteloremia (a pathology that affects some 100,000 persons in Spain).



The majority of those currently suffering from FH are not diagnosed as such. It is calculated that less than 30% of them have received a correct diagnosis with the majority receiving inadequate or inappropriate treatment. Moreover, when the illness is diagnosed, it is often too late as the patient a premature cardiovascular event which may be life-threatening.

Lipochip enables the early diagnosis of a large number of patients in a short space of time. In this way, cardiovascular illnesses can be prevented, these pathologies appearing in more than half of the patients affected by FH before 55 years of age. Amongst those between 20 and 39 years of age who suffer from Familial Hypercholesterolemia, mortality due to a coronary pathology is 100 times greater than amongst those without FH.


The importance of early diagnosis of FH with Lipochip lies in this high incidence of level of premature cardiovascular illnesses amongst FH patients. Without the correct diagnosis and treatment, many patients die between 35 and 65 years of age, and seven out of ten will suffer myocardiac attack before their sixtieth birthday. However, with early diagnosis and treatment, the survival rate and quality of life of patients improves, as these coronary events are greatly diminished. This also reduces hospital costs as there are less cardiovascular events amongst patients being suitably diagnosed and treated.

Early detection

Another important aspect, that can only be covered by the use of Lipochip, is the detection of the illness amongst young people who do not have symptoms but who, not being diagnosed early or receiving appropriate treatment, are subject to having an unexpected cardiovascular events. Up to now, the clinical diagnosis of FH has been based on typical clinical signs, on analytical data and on family history of the patient.

Thanks to the use of Lipochip, the illness can be diagnosed with complete reliability, i.e. knowing if the patient is a carrier of one of the mutations responsible for FH, using a small blood sample and in a matter of just a few days. Even in those patients that have a definite clinical diagnosis, the detection of the mutation may have prognostic value, given that some studies back up the hypothesis that the type of mutation may also have an influence on the response to pharmaceutical drugs, and so with the type of mutation determining the treatment.

Lipochip enables the carrying out of a genetic diagnosis of Familial Hypercholesterolemia, and considered to be of the greatest reliability. In this way, the appearance of false positives and false negatives are eliminated, which have arisen up to now using the diagnostic table of MedPed (the international programme of the World Health Organisation). The WHO, by means of this programme, recommended the development of techniques capable of detecting mutations in the LDL receptor gene in order to provide a reliable and early diagnosis of Familial Hypercholesterolemia. The mutations in this gene are the cause FH.

The principle of Lipochip is the capacity of DNA to recognise its complementary sequence.
Basically, it consists of a chemically modified glass surface onto which a large number of genic sequences complementary to each of the mutations have been deposited. To this surface the patient’s sample, marked with a fluorescent molecule, is added. Subsequent illumination with laser enables the identification of which of the points the patient’s blood sample has bonded to with greatest intensity. In this way specific discrimination between a normal patient and one suffering from Familial Hypercholesterolemia is established.

The novelty of this diagnostic tool is that it enables the analysis of thousands of sequences in a differentiated, rapid and reliable manner, unlike the traditional techniques of the independent analysis of each sequence in question, which can take months.

Lipochip has been designed and developed by the Progrenika-Medplant technological support group, based on knowledge provided by Familial Hypercholesterolemia Foundation and the Department of Biochemistry at the University of Zaragoza.


Contact :
Laureano Simón
Progenika S.A.
lsimon@progenika.com
(+34) 944064525

Garazi Andonegi | Basque research
Further information:
http://www.basqueresearch.com/berria_irakurri.asp?Gelaxka=1_1&Berri_Kod=408&hizk=I
http://www.progenika.com

More articles from Health and Medicine:

nachricht Study tracks inner workings of the brain with new biosensor
16.08.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Foods of the future
15.08.2018 | Georg-August-Universität Göttingen

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Color effects from transparent 3D-printed nanostructures

New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference

Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...

Im Focus: Unraveling the nature of 'whistlers' from space in the lab

A new study sheds light on how ultralow frequency radio waves and plasmas interact

Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

LaserForum 2018 deals with 3D production of components

17.08.2018 | Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

 
Latest News

Climate Impact Research in Hannover: Small Plants against Large Waves

17.08.2018 | Life Sciences

LaserForum 2018 deals with 3D production of components

17.08.2018 | Event News

Quantum material is promising 'ion conductor' for research, new technologies

17.08.2018 | Materials Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>